Karauda, T.; Miłkowska-Dymanowska, J.; Kumor-Kisielewska, A.; Piotrowski, W.J.; Białas, A.J.
Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD—A Pilot Study. J. Clin. Med. 2024, 13, 5188.
https://doi.org/10.3390/jcm13175188
AMA Style
Karauda T, Miłkowska-Dymanowska J, Kumor-Kisielewska A, Piotrowski WJ, Białas AJ.
Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD—A Pilot Study. Journal of Clinical Medicine. 2024; 13(17):5188.
https://doi.org/10.3390/jcm13175188
Chicago/Turabian Style
Karauda, Tomasz, Joanna Miłkowska-Dymanowska, Anna Kumor-Kisielewska, Wojciech J. Piotrowski, and Adam J. Białas.
2024. "Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD—A Pilot Study" Journal of Clinical Medicine 13, no. 17: 5188.
https://doi.org/10.3390/jcm13175188
APA Style
Karauda, T., Miłkowska-Dymanowska, J., Kumor-Kisielewska, A., Piotrowski, W. J., & Białas, A. J.
(2024). Interleukin 16 and 25 (IL-17E) and Clinical Outcomes in Exacerbation of COPD—A Pilot Study. Journal of Clinical Medicine, 13(17), 5188.
https://doi.org/10.3390/jcm13175188